Oxford Science Enterprises is an independent investment company that finds, funds, and builds transformational science and technology companies emerging from Oxford research.
Addition led the Series A round to support product development, hiring and global expansion.
"Thanks to an industry-leading team, decades of combined experience and a best-in-class product offering, PQShield has quickly emerged as a front runner and true authority in post-quantum cryptography for hardware and software, a field with enormous market potential. PQShield is already helping to define the future of information security, and we are excited to support their ongoing growth."
The Oxford biotech spinout secured $75m to expand international operations and scale its microscopy platform.
"ONI’s technology democratises cutting-edge science, enabling researchers to develop new angles to explore and understand the complexity of biological systems at super-resolution,"
The Oxford Science Enterprises-led round will support US expansion and continued domestic growth in healthcare.
"I’m delighted our investors have again demonstrated their belief in the vast potential that Navenio can bring by ensuring ‘right person, right place, right time’. Artificial intelligence is one of many technologies making a real-world impact in the health sector, and this investment enables the company to rapidly spearhead international digital transformation."
